Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Dr Reddy's Laboratories Ltd    500124   INE089A01023

DR REDDY'S LABORATORIES LTD

(500124)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mumbai Stock Exchange
11/29/2019 12/02/2019 12/03/2019 12/04/2019 12/05/2019 Date
2912.6 2870.55 2859.05 2878.7 2870.15 Last
11895 7679 7136 7478 11422 Volume
-2.16% -1.44% -0.40% +0.69% -0.30% Change
Financials (INR)
Sales 2020 170 B
EBIT 2020 23 648 M
Net income 2020 27 246 M
Finance 2020 13 152 M
Yield 2020 0,86%
Sales 2021 184 B
EBIT 2021 26 940 M
Net income 2021 23 669 M
Finance 2021 22 626 M
Yield 2021 0,86%
P/E ratio 2020 19,5x
P/E ratio 2021 20,2x
EV / Sales2020 2,75x
EV / Sales2021 2,49x
Capitalization 479 B
More Financials
Company
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows: - sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines; - sales of active ingredients (15.7%). The... 
Sector
Pharmaceuticals
Calendar
02/04Earnings Release
More about the company
Surperformance© ratings of Dr Reddy's Laboratories Lt
Trading Rating : Investor Rating :
More Ratings
Latest news on DR REDDY'S LABORATORIES LT
03:30aDR REDDY LABORATORIES : Announces the Launch of Deferasirox Tablets for Oral Sus..
BU
03:24aDR REDDY LABORATORIES : Announces the Launch of Deferasirox Film-Coated Tablets,..
BU
12/04DR REDDY LABORATORIES : Announces the Launch of Bortezomib for Injection 3.5 mg/..
BU
11/25DR REDDY LABORATORIES : announces launch of Doxercalciferol Injection in the U.S..
AQ
11/22DR REDDY LABORATORIES : announces launch of Doxercalciferol Injection in the U.S..
BU
11/18DR REDDY LABORATORIES : enters Nutrition Segment with Celevida in India
AQ
11/04DR REDDY LABORATORIES : . Reddy's Q2 & H1 FY20 Financial Results
AQ
11/01DOCTOR REDDY'S : Fiscal 2Q Earnings Snapshot
AQ
11/01DR REDDY LABORATORIES : . Reddy's Q2 & H1 FY20 Financial Results
BU
10/24DR REDDY LABORATORIES : . Reddy's confirms its voluntary nationwide recall of al..
AQ
10/23DR REDDY LABORATORIES : . Reddy's recalls heartburn ug over cancer-causing chemi..
AQ
10/23DR REDDY LABORATORIES : . Reddy's Recalls Ranitidine Medications in U.S.
DJ
10/23DR REDDY LABORATORIES : . Reddy's Confirms Its Voluntary Nationwide Recall of Al..
BU
10/14DR REDDY LABORATORIES : . Reddy's to release Q2 FY 20 results on November 1, 201..
BU
09/20DR REDDY LABORATORIES : . Reddy's Suspends Shipments of Ranitidine
DJ
More news
News in other languages on DR REDDY'S LABORATORIES LT
02/05INDIVIOR : paie cher sa dépendance au Subutex
More news
Sector news : Pharmaceuticals - NEC
12/05BILL GATES : Gates Foundation CEO Sue Desmond-Hellmann to step down after five y..
RE
12/05UK bribery investigation adds to Glencore's legal headaches
RE
12/05ROCHE : family adds new members to shareholder group to ensure continuity
RE
12/05ROCHE : FDA Approves Marketing of Roche Diagnostics MRSA Diagnostic Test
DJ
12/05DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
More sector news : Pharmaceuticals - NEC
Chart DR REDDY'S LABORATORIES LTD
Duration : Period :
Dr Reddy's Laboratories Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 35
Average target price 2 843,33  INR
Last Close Price 2 870,15  INR
Spread / Highest target 18,5%
Spread / Average Target -0,93%
Spread / Lowest Target -28,9%
EPS Revisions
Managers
NameTitle
Erez Israeli Chief Executive & Operating Officer
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR REDDY'S LABORATORIES LTD9.59%6 676
JOHNSON & JOHNSON8.14%367 304
ROCHE HOLDING AG25.10%263 429
MERCK AND COMPANY16.15%225 956
PFIZER-12.88%210 463
NOVARTIS21.74%207 450